Informed consent was not included in the published version of the following articles that appeared in previous issues of Leukemia Research Reports. Hence, the authors of the below articles were contacted after publication to request informed consent but have not responded by the time this erratum is being published:
-
1
“Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction” [Leukemia Research Reports, 2020; 14C: 100,228] 10.1016/j.lrr.2020.100228
-
2
“Rewriting the rules for care of MDS and AML patients in the time of COVID-19″ [Leukemia Research Reports, 2020; 13C: 100,201] 10.1016/j.lrr.2020.100201
-
3
“Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review” [Leukemia Research Reports, 2019; 12C: 100,172] 10.1016/j.lrr.2019.100172
-
4
“A rare case of acute myeloid leukemia with der(1)t(1;19)(p13;p13.1)” [Leukemia Research Reports, 2019; 12C: 100,175] 10.1016/j.lrr.2019.100175
-
5
“Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia” [Leukemia Research Reports, 2019; 12C: 100,185] 10.1016/j.lrr.2019.100185
-
6
“Chronic myelomonocytic leukemia as a transformation from polycythemia vera” [Leukemia Research Reports, 2019; 11C: 14-16] 10.1016/j.lrr.2019.03.004